United States · FDA National Drug Code directory
STRENSIQ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25682-019_404d99e5-991e-4353-bb9f-29dfa00a43b3
- Product NDC
- 25682-019
- Form
- SOLUTION
- Composition / generic term
- ASFOTASE ALFA
- Labeler
- Alexion Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20151023
- Source listing expiry
- 20261231
Source-listed ingredients
- ASFOTASE ALFA — 80 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 VIAL in 1 CARTON (25682-019-12) / .8 mL in 1 VIAL (25682-019-01) · 25682-019-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →